← FDA ENFORCEMENT
Z-1816-2026Class II
Integra LifeSciences Corp. (NeuroSciences)
What this record is not
A recall record is reproduced as FDA published it, and the classification is FDA’s. SPEQ adds no interpretation, and a recall concerns the products and dates in the record — it is not a statement about a company’s other products or its current status.
Recalling firm
Integra LifeSciences Corp. (NeuroSciences)
Product type
Device
Status
Ongoing
Report date
2026-04-22
Distribution
US Nationwide distribution in the states of AL, AZ, CA, DC, FL, GA, IA, IL, KS, KY, LA, MD, ME, MN, MO, MT, NC, ND, NE, NJ, NY, OH, PA, SC, SD, TN, TX, VA, VT, WA, WI, WV.
Firm state
NJ
Product quantity
148 units
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Environmental MonitoringReason for recall
Increased rate of out-of-specification endotoxin results.
Product description
Cytal Wound Matrix 2-Layer 5x5 cm. Product ID: WSM0505.
Code / lot info
Product ID: WSM0505. UDI-DI: 00386190001431. Lot Numbers: 7579683, 7583933, 7583891, 7583935, 7594266, 7594286, 7593011.
Data: U.S. FDA. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Open the enforcement explorer →